Sgpl Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Sgpl Pharma
Sgpl Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 1997 and has a history of 27 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ritika Modi and Chander Modi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239DL1997PTC090294
- Company No.
090294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1997
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sgpl Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritika Modi  | Director | 05-Apr-2012 | Current |
| Chander Modi | Director | 05-Apr-2012 | Current |
Financial Performance of Sgpl Pharma.
Sgpl Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sgpl Pharma?
In 2017, Sgpl Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Indo-Canadian Business ChamberRitika Modi is a mutual person
Mod Fashions And Securities Private LimitedRitika Modi and Chander Modi are mutual person
Uniglobe Mod Travels Private LimitedRitika Modi is a mutual person
Modi Marco Aldany Private LimitedRitika Modi is a mutual person
Lumax Industries LimitedRitika Modi is a mutual person
A' La Mode Garments Private LimitedRitika Modi and Chander Modi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sgpl Pharma?
Unlock and access historical data on people associated with Sgpl Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sgpl Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgpl Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
